Algeta to host Capital Markets Days


OSLO, Norway, Nov. 18, 2013 (GLOBE NEWSWIRE) --

Intended for US media only

Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, will host Capital Markets
Days this week in Oslo, London and New York.

Event summaries and guest speaker details are provided below.

Oslo, 18 November 10:00am-2:00pm (CET)
KS-Agenda Møtesenter, Haakon VII's gate 9

  * Dr Dag Clement Johannessen, Consultant Oncologist, Department of Oncology,
    University Hospital of Oslo, Norway
  * Dr Sten Nilsson, Professor of Oncology, Karolinska Institutet and University
    Hospital, Stockholm, Sweden

London, 19 November 10:00am-2:00pm (GMT)
Holborn Bars 2(nd) Floor, 138-142 Holborn

  * Dr E. David Crawford, Professor of Surgery (Urology) & Radiation Oncology,
    Head Urologic Oncology, University of Colorado, Denver, USA
  * Dr Sten Nilsson, Professor of Oncology, Karolinska Institutet and University
    Hospital, Stockholm, Sweden

New York, 21 November 12.30pm-4:30pm (EDT)
Parker Meridien, 118 West 57(th) Street

  * Dr Dan George, Director, GU Oncology, Duke Cancer Institute, Duke University
    Medical Center, Durham, North Carolina, USA
  * Dr Neal D. Shore, Director, CPI, Carolina Urologic Research Center, Atlantic
    Urology Clinics, Myrtle Beach, South Carolina, USA

The  event in New  York will be  webcast via www.algeta.com, where presentations
will also be made available.


                                      ###

For further information, please contact:

 Mike Booth                             +1 646 410 1884

 Communications & Corporate Affairs     ir@algeta.com



 Media enquiries:

 Mark Swallow                           +44 207 638 9571

 Citigate Dewe Rogerson                 mark.swallow@citigatedr.co.uk



 Kari Watson                            +1 781 235 3060

 MacDougall Biomedical Communications   kwatson@macbiocom.com



 Investor enquiries:

 Tricia Truehart                        +1 646 378 2953

 The Trout Group                        ttruehart@troutgroup.com


About Algeta

Algeta is a company focused on developing, manufacturing and marketing novel
targeted therapies for patients with cancer. The Company is headquartered in
Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA
performing commercial marketing operations in the US. Algeta is listed on the
Oslo Stock Exchange (Ticker: ALGETA). For more information please visit
www.algeta.com.




Press release: http://hugin.info/134655/R/1743766/586643.pdf

[HUG#1743766]